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Abstract 1 
Background and aim: Participation in decision-making, supported by comprehensive and quality 2 
information provision, is increasingly emphasised as a priority for women in maternity care. Patient 3 
decision aids are tools that can offer women greater access to information and guidance to participate in 4 
maternity care decision-making. Relative to their evaluation in controlled settings, the implementation of 5 
patient decision aids in routine maternity care has received little attention and our understanding of which 6 
approaches may be effective is limited. This paper critically discusses the application of patient decision 7 
aids in routine maternity care and explores viable solutions for promoting their successful uptake. 8 
Discussion: A range of patient decision aids have been developed for use within maternity care, and 9 
controlled trials have highlighted their positive impact on the decision-making process for women. 10 
Nevertheless, evidence of successful patient decision aid implementation in real world health care settings 11 
is lacking due to practical and ideological barriers that exist. Patient-directed social marketing campaigns 12 
are a relatively novel approach to patient decision aid delivery that may facilitate their adoption in 13 
maternity care, at least in the short-term, by overcoming common implementation barriers. Social 14 
marketing may also be particularly well suited to maternity care, given the unique characteristics of this 15 
health context. 16 
Conclusions: The potential of social marketing campaigns to facilitate patient decision aid adoption in 17 
maternity care highlights the need for pragmatic trials to evaluate their effectiveness. Identifying which 18 
sub-groups of women are more or less likely to respond to these strategies will further direct 19 
implementation.  20 
1.  Background 21 
Patient decision aids (PtDAs) are fast emerging as tools to potentially change health care delivery 22 
globally, affording patients greater access to quality information and facilitating their participation in 23 
health care decision-making. Information provision and participation in decision-making for women has 24 
been increasingly emphasised as a priority in maternity care1-3 since publication of the landmark 25 
Changing Childbirth report in the UK over two decades ago.4 In light of this, PtDAs have been developed 26 
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for use across a range of decisions within the maternity care context. The implementation of PtDAs in 27 
routine maternity care is a recent focus and, as such, we have a very limited understanding of which 28 
approaches may be effective at promoting their successful uptake. This paper discusses the potential 29 
benefits of patient decision aids in maternity care, as well as known barriers to their use and new 30 
opportunities that may support successful implementation. 31 
2.  Patient Decision Aids Can Address Women’s Maternity Care Needs 32 
PtDAs are tools (e.g., audio booklets, pamphlets, video/computer-based programs, web-based tools) 33 
designed to improve decision-making processes and outcomes for patients across a variety of health care 34 
domains. In maternity care, facilitating women‟s access to and use of PtDAs responds to existing care 35 
needs and priorities, and offers numerous additional benefits. Important and complex decisions are made 36 
at various stages throughout a woman‟s pregnancy, labour and birth. Examples include deciding on a 37 
model of maternity care (i.e., where and with whom to give birth), whether to have antenatal screening, 38 
how to manage pain during labour, whether to have a vaginal or caesarean birth, and how to manage a 39 
prolonged pregnancy. For these decisions, women often have more than one reasonable care option and/or 40 
there may be scientific uncertainty as to which option is more beneficial.5 These are often referred to as 41 
„preference-sensitive‟ decisions, for which quality decision-making is not only reliant on clinical 42 
expertise, but also a woman‟s individual preferences in relation to perceived advantages and disadvantage 43 
of her care options.6  44 
Both informed and shared decision-making models are commonly used to describe the processes 45 
involved in quality preference-sensitive decision-making, and have been encouraged in maternity care 46 
specifically.1,2,7,8 In their seminal work, Charles, Whelan, and Gafni (1999) describe informed decision-47 
making as a care provider communicating information on all care options and a patient engaging in 48 
autonomous deliberation and decision-making, whilst in shared decision-making, both care provider and 49 
patient engage in information sharing (e.g., provider on care options, patient on personal preferences), and 50 
mutual deliberation and decision-making.9 In reality, both decision-making styles often occur in a 51 
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dynamic nature and the degree to which a patient participates in the decision-making process should 52 
ultimately reflect their own informed preferences for involvement.9 53 
Previous studies have highlighted that most pregnant women want to be involved in decision-making 54 
about their care.10,11 While maternity care providers are a common source of pregnancy-related 55 
information,12 the information they provide can be insufficient to effectively support women‟s 56 
involvement.12-15 Maternity care providers have limited time in consultations, and find it difficult to 57 
maintain and share up-to-date knowledge of current evidence or available care options.16,17 PtDAs offer 58 
women an opportunity to become informed in a reliable and balanced way and can prepare them to 59 
participate in the decision-making process to their preferred extent. Like other health contexts, PtDAs in 60 
maternity care are designed as adjuncts to consultation with a maternity care provider.18 According to 61 
quality standards, they should provide detailed but accessible descriptions of available care options for 62 
specific maternity care decisions, including information on what women can expect from each care option 63 
(e.g., processes and option features) and the likelihood of experiencing particular health-related outcomes, 64 
based on the best available evidence.19-21 Ideally, PtDAs should also include strategies to help women 65 
deal with large amounts of information and strategies for effectively communicating their preferences and 66 
concerns with their maternity care provider.21  67 
There is emerging evidence of the benefits of PtDAs for women receiving maternity care. To date, 68 
three separate systematic reviews have summarised findings from randomised controlled trials assessing 69 
the effectiveness of PtDAs in improving decision-making processes and outcomes for pregnant women.22-70 
24 These trials compared women receiving usual maternity care to those who used a PtDA, either prior to 71 
or during a clinical encounter, across a range of preference-sensitive decisions that pregnant women 72 
commonly face. All three reviews concluded that PtDA use resulted in women‟s increased knowledge of 73 
care options, and decreased decisional conflict (e.g., uncertainty about a decision, and contributing factors 74 
such as feeling uninformed, unclear about values, and unsupported in decision-making) and anxiety. 75 
Women‟s use of PtDAs may also have additional benefits. Patients who are informed of their options 76 
and the likely outcomes have been found to choose more conservative (and possibly, less costly) options 77 
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than other patients, in both hypothetical25 and actual situations.18 PtDA use can also reduce unwarranted 78 
(i.e., not due to patients‟ clinical circumstances or preferences) variation in maternity care practice1,26 and 79 
health system demand.18 Providing women access to reliable information and decision support also 80 
preserves their right to self-determination and responds to current directions to increase patient 81 
empowerment in health care more broadly.27,28 Despite the demonstrated benefits from controlled trials, 82 
and potential benefits in moving overall practice in a more patient-centred direction, there is little 83 
evidence of effective and sustained implementation of PtDAs in routine clinical practice in maternity 84 
care29 or other areas of health care.30-32 85 
3.  Early Findings From Within Maternity Care 86 
To date, only two studies have been published specifically exploring PtDA implementation in 87 
maternity care: a pragmatic trial on the impact of implementing PtDAs (referred to in this study as 88 
evidence based leaflets) in routine hospital settings29,33 and a focus group analysis of maternity care 89 
providers‟ perceptions of future PtDA use.16 An unpublished analysis of the process of developing a suite 90 
of perinatal PtDAs in consultation with consumer groups, clinicians and policy-makers in Australia has 91 
also highlighted potential implementation hurdles.34 In all three examples, many care providers supported 92 
the general concept of patient involvement in decision-making, yet a number of ideological and practical 93 
barriers to the routine implementation of PtDAs were apparent. 94 
Ideological barriers to implementation were particularly salient. In the pragmatic trial which was 95 
largely unsuccessful, embedded practice norms (e.g., routine universal intervention such as foetal 96 
monitoring) prevented providers‟ distribution of PtDAs to patients as they presented care options that 97 
deviated from usual practice.33 In other studies, providing patients with balanced and unbiased 98 
information about all available care options (including the options to „do nothing‟) was considered 99 
inappropriate if PtDAs focused on a decision that was considered not to be preference-sensitive, if care 100 
providers valued their own autonomy in decision-making,34 or if patients and providers had strong pre-101 
existing preferences for a particular care option.16 Care providers consistently expressed concerns about 102 
the limited usability of PtDAs due to the characteristics of some women (e.g., low levels of formal 103 
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education, poor computer literacy skills, cultural barriers).16,33,34 Practical barriers to implementation 104 
largely included care providers‟ concerns about existing time pressures within already time-poor clinic 105 
workflows.16,33 Perceived costs associated with additional resource needs (e.g., purchasing computers for 106 
PtDA viewing) and limited in-clinic space for patients to view PtDAs were also voiced as concerns.16 In 107 
addition to these barriers, providers in one study believed that PtDA uptake could be facilitated if the 108 
delivery of PtDAs was integrated with minimal disruption to women‟s existing pregnancy care, if PtDAs 109 
were self-accessible to women at home (such as via the internet), and if provider awareness of and 110 
support for PtDAs was enhanced.16 111 
4.  Current Delivery Opportunities 112 
Although a range of different PtDA implementation strategies have been evaluated outside maternity 113 
care, a best practice approach has yet to be identified.30 A core component of any PtDA implementation 114 
strategy is the method/s by which PtDAs are delivered to patients. Delivery strategies in primary and 115 
specialty care have included identification of eligible patients with clinic bookings through electronic 116 
health records and mailing them PtDAs (electronically or via post);30,32,35 clinic staff (e.g., administrative 117 
staff, health coaches, decision support counsellors) distributing PtDAs to patients in-clinic before or after 118 
consultations;30-32 or care providers „prescribing‟ PtDAs within or following a consultation for subsequent 119 
patient viewing.30-32,35 Delivery that hinges on providers remembering to prescribe PtDAs has been 120 
relatively unreliable due to time constraints within consultations and provider attitudes toward PtDAs 121 
and/or patient participation in decision-making in general.30-32,35 Strategies that are not reliant on providers 122 
to distribute PtDAs (e.g., automated delivery, distribution by clinic staff) have been much more effective 123 
at ensuring patient receipt of PtDAs,30,32,35 but have still encountered obstacles in many settings due to 124 
limited infrastructure/information systems to identify eligible patients and a lack of supportive 125 
organisational culture.32,35  126 
An innovative and less explored approach to PtDA delivery is patient-directed social marketing. Social 127 
marketing has been variably definede.g.,36,37 and when applied in a health care context broadly involves the 128 
adaptation of commercial marketing concepts and techniques to promote public health and wellbeing.38,39 129 
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Social marketing has been employed in health settings both within and outside maternity care, to promote 130 
patient use of PtDAs31,40 as well as raise awareness of, and encourage patient participation in decision-131 
making.41-43 Desipte its broad application in the context of patient engagement, to our knowledge, the 132 
direct impact of social marketing on PtDA uptake and/or rates of patient participation in decision-making 133 
has yet to be evaluated. 134 
Recently, across five primary care practices in the U.S., a patient-directed social marketing campaign 135 
(including brochures/posters in clinics and social media presence) was rolled out as one component of a 136 
multi-faceted PtDA implementation project.31,44 Brief self-screening surveys were also distributed in 137 
clinics, that allowed patients to identify eligibility and independently request relevant PtDAs. Key 138 
messages communicated across the marketing campaign included explanation about the existence of 139 
multiple treatment or care options for particular health conditions (e.g., chronic pain, knee osteoarthritis, 140 
colon cancer); the benefits for patients of knowing their options and considering what is important to 141 
them; the role of PtDAs in this process; and encouragement to request PtDAs. Such comprehensive 142 
messages can serve as „invitations‟ for patients to participate in decision-making,45 and may address 143 
patient concerns about the relevance and role of PtDAs in the absence of this being communicated by 144 
one‟s care provider. Overall, increases in PtDA uptake were observed across the duration of the multi-145 
faceted implementation project,44 however, the unique influence of social marketing was not evaluated. 146 
Further examples include the use of patient-directed social marketing campaigns in a range of primary 147 
and specialty care settings to encourage patients to ask questions in consultations to facilitate shared 148 
decision-making.41-43 Program evaluations suggest that the campaigns were generally well received by 149 
patients and providers, yet again, their unique impact on patient involvement in consultations was difficult 150 
to determine due to the implementation of social marketing alongside other patient- and provider-directed 151 
strategies. 152 
5.  Patient-Directed Social Marketing in Maternity Care 153 
Patient-directed social marketing is an ideal method to overcome several prevailing practical barriers 154 
to implementation and encourage women‟s self-managed access to PtDAs in maternity care.16 Reliance 155 
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on maternity care providers to distribute PtDAs is reduced so it can also alleviate the influence of salient 156 
ideological barriers on access.16,33,34 Several factors unique to maternity care make patient-directed social 157 
marketing particularly relevant to this health context. Women are faced with multiple decisions across the 158 
pregnancy, labour and birth period for which PtDAs apply1 and investing resources in marketing the 159 
availability of a PtDA for one decision may lead to greater awareness and uptake of other PtDAs. Greater 160 
flexibility in the timing of PtDA delivery that patient-directed uptake provides is also fitting, given the 161 
extended time period that women have to deliberate for many pregnancy-related decisions (i.e., those 162 
relevant to labour and birth, or the postnatal period). Patient-directed marketing is less labour intensive 163 
and thus likely to be highly transferable across the range of settings where maternity care is provided 164 
(e.g., community/primary care clinics, birth centres, hospitals) including those with limited resources and 165 
infrastructure. Many PtDAs relevant to pregnancy and birth also do not require a formal clinical diagnosis 166 
to determine patient applicability. 167 
Furthermore, the distinct characteristics of pregnant women suggest that social marketing may be 168 
particularly effective at facilitating their uptake of PtDAs. Pregnancy is generally regarded as a positive 169 
life experience, unlike that of disease or illness. Pregnant women are already motivated to seek out 170 
information to better understand aspects of pregnancy, labour, and birth12,46 and as previously stated, have 171 
near universal preferences for involvement in decision-making.10,11 Pregnant women are also younger, on 172 
average, than patients in general. They are thus less likely to be impaired by cognitive deficits or 173 
experience negative health symptoms that can reduce patients‟ interest in decision-making involvement 174 
and their ability to use PtDAs.47 Campaigns that promote the availability of self-accessible web-based 175 
PtDAs may be particularly advantageous, since many women are familiar with accessing pregnancy-176 
related information via the internet.1,12,46,48 177 
Like other delivery strategies, patient-directed social marketing has some limitations. Although patient 178 
„push‟ to actively participate in decision-making may alone influence provider behaviour in 179 
consultations,49 patient-directed social marketing does not directly target the paternalistic ideologies that 180 
prevent care providers from supporting patient autonomy and sharing decision-making processes with 181 
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patients. It may be a necessary step in facilitating PtDA uptake and awareness in the short-term, while we 182 
seek to better understand how to successfully engage maternity care providers and support long-term 183 
implementation.  184 
There are additional opportunities for engaging maternity care providers, however, the challenge lies 185 
in identifying which strategies will be effective in different maternity care settings as well as ensuring 186 
there are necessary resources to support their sustained implementation. Provider training sessions on the 187 
effective use of PtDAs and involvement of patients in the decision-making process42,45,50 and the 188 
development of single-page decision support tools (i.e., Option Grids) specifically designed to expedite 189 
the patient-provider decision-making process within clinical consultations41,42,51 exhibit potential for 190 
enhancing provider commitment to shared decision-making/PtDA implementation efforts in broader 191 
health care. Where possible, maximising providers‟ agreement with PtDA content may also help to shift 192 
existing unsupportive ideologies and their contribution to the design process may highlight further 193 
barriers and facilitators to engagement34,52 to which implementation plans can respond. Those seeking to 194 
evaluate the above strategies should ensure that maternity care providers are involved at all stages of their 195 
design and implementation, so that strategies can be tailored to the unique needs and capabilities of 196 
individual care settings.42,45 197 
6.  Conclusions and Future Directions 198 
Developing and testing methods to facilitate the adoption of PtDAs in maternity care settings and 199 
further engage women as active participants in their own care, brings us one step closer to achieving 200 
maternity care delivery that is patient-centred and safe.  The potential of social marketing campaigns for 201 
early PtDA adoption in maternity care settings highlights the need for trials to determine their 202 
effectiveness. Trials should be pragmatic in nature and incorporate an evaluation of which sub-groups of 203 
women are more or less likely to respond to patient-directed strategies. This would allow us to determine 204 
where and to whom these strategies should be directed, in order to focus early implementation on those 205 
who need and want it most. Achieving sustained PtDA uptake and use will likely necessitate significant 206 
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Government and health service investment to support the continued availability of multiple 207 
implementation strategies that respond to the diverse needs of women and providers.  208 
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